Revolution Medicines: "Strong Buy" As Acquisition Prospects Continue To Circle

Core Insights - The article discusses Revolution Medicines (RVMD) and its potential in targeting previously considered "undruggable" targets, suggesting that these targets are now potentially druggable [2]. Company Overview - Revolution Medicines is highlighted as a company that is making strides in the biotech sector, particularly in the development of therapies for challenging targets [2]. Analyst Background - The author, Terry Chrisomalis, has extensive experience in the biotech sector and runs the Biotech Analysis Central service, which provides in-depth analysis and resources for healthcare investors [2].